| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Naproxen | FAERS: 4 | US FAERS | |
| 2 | Amiodarone | FAERS: 1 | US FAERS | |
| 3 | Bimatoprost | FAERS: 1 | US FAERS | |
| 4 | Bisoprolol | FAERS: 1 | US FAERS | |
| 5 | Dabigatran | FAERS: 1 | US FAERS | |
| 6 | Digoxin | FAERS: 1 | US FAERS | |
| 7 | LCZ 696 | FAERS: 1 | US FAERS | |
| 8 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 9 | PCI 32765 | FAERS: 1 | US FAERS | |
| 10 | Procarbazine | FAERS: 1 | US FAERS | |
| 11 | Teriparatide | FAERS: 1 | US FAERS | |
| 12 | apremilast | FAERS: 1 | US FAERS | |
| 13 | rofecoxib | FAERS: 1 | US FAERS | |
| 14 | tofacitinib | FAERS: 1 | US FAERS | |
| 15 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | OFFSIDES | ||
| 16 | Bupropion | OFFSIDES | ||
| 17 | Fluvoxamine | SIDER | ||
| 18 | Venlafaxine Hydrochloride | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.